Core Viewpoint - The company has transitioned from water treatment to focus on the C5 comprehensive utilization sector, with its petrochemical business becoming the core, despite facing challenges in revenue growth and increased competition [1] Group 1: Business Overview - The company's main products include isoprene, piperylene, and C5 petroleum resins, with a slight decline in revenue but a rapid recovery in gross margin for the petrochemical segment, leading to a modest rebound in profitability [1] - The company is entering a phase of concentrated implementation and transformation of R&D achievements, with plans for a high-end new materials project in Jieyang focusing on C4/C5 [1] Group 2: C5 Industry Chain - The raw material side is seeing significant cost optimization due to increased supply of cracked C5, driven by the rapid expansion of ethylene capacity and declining oil prices, which is expected to improve profitability [2] - The demand side faces intensified competition in traditional deep processing markets, with a focus on high-end new materials like SBC, which are versatile in various applications [2] Group 3: High-end New Materials Projects - The company is leveraging its petrochemical park locations to establish high-end new materials projects, including a 62,000-ton elastomer project capable of producing various SBC products [3] Group 4: Environmental New Materials - TPE is gaining traction as an eco-friendly alternative to traditional leather and synthetic leather, with significant advantages in durability and performance, aligning with the "dual carbon" goals [4] - The company plans to invest approximately 1 billion yuan in automotive interior materials, with a minimum of 800 million yuan allocated for fixed assets, aiming to establish 20 production lines for various leather products by June 2025 [4] Group 5: Investment Outlook - As a leading player in the domestic C5 deep processing sector, the company is projected to have a net profit of -180 million yuan in 2025, followed by 230 million yuan in 2026 and 410 million yuan in 2027, with corresponding PE ratios of 32.3X and 18.3X for 2026 and 2027 respectively, initiating coverage with a "buy" rating [5]